Last reviewed · How we verify
NCT06733701
The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization
NA trial testing VR-based intervention (VRReliever Software V0.3.4 fromXRHealth) in Oocyte Retrieval in 50 participants. Not yet recruiting.
15 July 2025
Quick facts
| Lead sponsor | Mount Sinai Hospital, Canada |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 15 January 2025 |
| Primary completion | 15 July 2025 |
| Estimated completion | 31 December 2025 |
Drugs / interventions tested
- VR-based intervention (VRReliever Software V0.3.4 fromXRHealth)
- VR headset without any scenery
Conditions studied
- Oocyte Retrieval — all drugs for Oocyte Retrieval →
- Adverse Events — all drugs for Adverse Events →
- Procedural Anxiety — all drugs for Procedural Anxiety →
- Pain Intensity — all drugs for Pain Intensity →
Sponsor
Mount Sinai Hospital, Canada
Who can join
Adults 18 to 43, female only, with Oocyte Retrieval or Adverse Events. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ultrasound-guided oocyte retrieval (OR) is a short, but oftentimes painful procedure, during which the follicles are punctured trans-vaginally to obtain oocytes for in vitro fertilization (IVF). Conscious sedation is the most commonly used method of pain relief, yet several studies have shown that more than half of women report moderate to high levels of pain and up to 7% of women report extreme or unacceptable levels of pain during OR. Adjuvant virtual reality (VR) therapy has been explored to reduce psychological stress during dental procedures, burn wound care, colonoscopy, as well as other minor procedures. Hence, the purpose of this study is to evaluate the use of VR technology during IVF treatment, particularly with respect to tolerability, patient satisfaction, and pain reduction during oocyte retrieval.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06733701
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oocyte Retrieval
Currently open trials in the same condition.
- NCT07262216 — Correlation Between Pain Threshold and Analgesic Consumption in Transvaginal Oocyte Aspiration Patients · active not recruiting
Other Mount Sinai Hospital, Canada trials
Trials by the same sponsor.
- NCT07272460 — Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial · NA · recruiting
- NCT07046572 — Methoxyflurane for IUD Insertion and Endometrial Biopsy · NA · recruiting
- NCT06504277 — Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain · NA · recruiting
- NCT06546254 — 1% Lidocaine Paracervical Block for Endometrial Biopsy · NA · completed
- NCT06637319 — Prevalence of Major Vessels Underlying the Potential Incision Site for Emergency Front of Neck Airway Access in Adult Su · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06733701 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mount Sinai Hospital, Canada
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06733701.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing